Roeland Huijgen

Hoofddorp, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.

LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia.

Journal: Atherosclerosis
Published: February 26, 2024

Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model.

Adherence to statin treatment in patients with familial hypercholesterolemia: A dynamic prediction model.

Journal: Journal of clinical lipidology
Published: June 16, 2022

Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.

Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.

Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 05, 2020

Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation.

Statin therapy reduces plasma angiopoietin-like 3 (ANGPTL3) concentrations in hypercholesterolemic patients via reduced liver X receptor (LXR) activation.

Journal: Atherosclerosis
Published: July 20, 2020

Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program.

Interpretation of laboratory results after gastric bypass surgery: the effects of weight loss and time on 30 blood tests in a 5-year follow-up program.

Journal: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
Published: July 09, 2020

Risk Factors for Cholecystectomy After Laparoscopic Roux-En-Y Gastric Bypass.

Risk Factors for Cholecystectomy After Laparoscopic Roux-En-Y Gastric Bypass.

Journal: Obesity surgery
Published: November 21, 2019

LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.

LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.

Journal: Atherosclerosis
Published: April 12, 2018

Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy.

Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy.

Journal: Journal of clinical lipidology
Published: October 13, 2017

Determining When to Add Nonstatin Therapy: A Quantitative Approach.

Determining When to Add Nonstatin Therapy: A Quantitative Approach.

Journal: Journal of the American College of Cardiology
Published: June 07, 2016

Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.

Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.

Journal: Journal of the American College of Cardiology
Published: April 01, 2016

Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.

Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.

Journal: Atherosclerosis
Published: October 31, 2015

PCSK9 inhibition: the way forward in the treatment of dyslipidemia.

PCSK9 inhibition: the way forward in the treatment of dyslipidemia.

Journal: BMC medicine
Published: July 09, 2015
Showing 1-12 of 30

Last Updated: 09/26/2026